bioAffinity Technologies
@bioAffinity
Followers
236
Following
36
Media
329
Statuses
414
Joined June 2020
With something as essential as breath, every moment matters. Early detection saves lives. Let’s keep pushing for awareness and action. #WorldLungCancerDay #EarlyDetection #LungCancerAwareness #CyPathLung
0
0
4
Dr. Gordon Downie describes how real-time results from a CyPath® Lung test lead to quick actionable steps and peace of mind for patients. #CyPathLung #EarlyDetection #LungCancer #Diagnostics
2
1
5
“CyPath® Lung gave us the clarity we needed to act early,” said Dr. Gordon Downie, CMO, referring to a Stage 1A mucinous adenocarcinoma missed by other diagnostics. Every early diagnosis is a life potentially saved. Read PR: #CyPathLung #LungCancer
0
1
4
New case study: noninvasive CyPath® Lung detected a Stage 1A neuroendocrine tumor that PET, bronchoscopy & serum markers missed, leading to timely surgical removal. Noninvasive. Precise. Life‑saving. Full PR: #LungCancer #CyPathLung #PhysicianHighlights
0
1
6
Canada awards patent for CyPath® Lung, expanding global protection of our noninvasive test for early lung cancer detection. With 92% sensitivity and 88% accuracy, early diagnosis can save lives. PR: #CyPathLung #LungCancer #Diagnostics #Biotech #Canada.
bioaffinitytech.com
New patent protects market expansion to the north where lung cancer is leading cause of cancer deaths SAN ANTONIO, TX — July 22, 2025 — bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a...
1
3
5
CyPath® Lung gives physicians timely, actionable insights for patients at risk of lung cancer. Early detection is critical. Fast results save lives. Noninvasive. Accurate Results. Watch here: #CyPathLung #LungCancer #PhysicianHighlights
0
0
4
“Securing this IP positions us well for future opportunities in one of the world’s largest and most underserved healthcare markets.”.Maria Zannes, President & CEO.CyPath® Lung has shown 92% sensitivity, 87% specificity.Read the press release: #LungCancer.
bioaffinitytech.com
One third of world’s smokers live in China, which has highest rate of lung cancer SAN ANTONIO, TX — July 15, 2025 — bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company...
0
1
4
Quick, accurate, and patient-centered. CyPath® Lung delivers actionable results in 3 days empowering better clinical decisions, faster. See what NP Israel Garcia says about its impact on care. Check it out:#CyPathLung #LungCancer #PhysicianHighlights
0
1
4
Detected Stage 1A lung cancer and gave “the confidence to intervene surgically when everything else pointed to watchful waiting,” Dr. Gordon Downie.Early detection led to timely care. PR: #CyPathLung #EarlyDetection #LungCancer #PhysicianHighlights
0
1
7
Happy 4th of July!.Celebrating the freedom to innovate and the power of science to save lives. #IndependenceDay #FourthOfJuly #HealthcareInnovation
0
0
3
92% sensitivity, 87% specificity in detecting lung cancer in high-risk patients with nodules <20mm. Backed by data. Trusted by physicians. Built for market growth. Learn more: #CyPathLung #CancerDiagnostics #LungCancer #InvestorInsight
0
1
3
Lung cancer accounts for nearly 1 in 5 cancer related fatalities. The solution? Early detection and diagnosis. CyPath® Lung offers 92% sensitivity & 87% specificity w/nodules <20mm. Check it out: #CyPathLung #EarlyDetection #LungCancer #DoctorHighlights
0
1
2
Exciting data from Dr. Dave Elzi at the #RNATherapeutics Conference: the double knockdown of specific proteins on the cell membrane selectively kills cancer cells while sparing healthy tissue. A powerful step forward in RNA-based precision oncology. #Cancer #bioAffinity
1
0
6
New Chinese patent is another milestone in our mission to develop smarter, more selective cancer therapies. 🔬 Targeted.✅ Non-toxic to normal cells.🌍 Globally protected IP.Read the news release at #bioAffinity #CancerResearch #NewPatent #RNAi #Biotech
0
0
4
Linda thought she was healthy, a low-dose CT scan caught lung cancer early, before symptoms appeared. Early detection made all the difference. Tools like CyPath® Lung help doctors take the next step.Read her story: #CyPathLung #SavedByTheScan.
0
0
0
Noninvasive. Fast results. CyPath® Lung helps identify malignant lung nodules in just 3 days. See how Dr. Nadarajah uses it in his practice: #CyPathLung #EarlyDetection #LungCancer #PhysicianHighlights
0
0
1
Today, we honor #Juneteenth, marking a pivotal moment in our history. Inspired by this spirit of resilience, bioAffinity is committed to advancing health solutions that serve all communities in their journey towards health and well-being.#Juneteenth2025 #EquityInHealth #CyPath
0
0
1
RT @LungAssociation: Christy had a 2% chance of survival. Today, she’s a 17-year lung cancer survivor. 💙 Research saved her life and more b….
0
2
0
To all the amazing dads: Happy Father's Day! At bioAffinity, we're celebrating you and the healthy future you build for your families. Here's to many more cherished moments! #FathersDay2025 #MensHealth #bioAffinity #DadLove
1
0
2
Don't miss out! Today @ 2 PM ET, our CEO Maria Zannes joins @CardinalHealth OptiFreight GM Emily Gallo & @ClevelandClinic Supply Chain Exec Sarah Charai for a webinar on logistics & patient care!.Register: #bioAffinity #CardinalHealth #ClevelandClinic
0
0
0